# P1.01-22 Investigation of Acquired Resistance for EGFR-TKI Plus Bevacizumab as 1st Line Treatment in Patients with EGFR Sensitive Mutant NSCLC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p1-01-22-investigation-of-acquired-resistance-for-egfr-tki-plus-bevacizumab-as/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Y. Zhang,L. Zeng,Nong Yang,Tao Jiang,C. Zhou |
| Citations | 0 |
| DOI | 10.1016/j.jtho.2019.08.737 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086419314200/pdf |
| OpenAlex ID | https://openalex.org/W2981722047 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Y. Zhang](https://scholariq.org/researchers/y-zhang-2/)
- [L. Zeng](https://scholariq.org/researchers/l-zeng/)
- [Nong Yang](https://scholariq.org/researchers/nong-yang/)
- [Tao Jiang](https://scholariq.org/researchers/tao-jiang/)
- [C. Zhou](https://scholariq.org/researchers/c-zhou/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.